Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank14
Studio
Year-over-Year Change

Debt-to-equity ratio

Latest
0.00
↓ 100% vs avg
Percentile
P14
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
3.72
Historical baseline
PeriodValueYoY Change
20250.00-100.0%
20244.14-76.9%
202317.89+101.7%
20228.87+99.3%
20214.45+69.3%
20202.63-40.1%
20194.39+764.0%
20180.51-47.7%
20170.97+114.6%
2016-6.67-